• Je něco špatně v tomto záznamu ?

Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing

T. Tikkanen, B. Leroy, JL. Fournier, RA. Risques, J. Malcikova, T. Soussi,

. 2018 ; 39 (7) : 925-933. [pub] 20180517

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028461

Grantová podpora
R01 CA181308 NCI NIH HHS - United States

Accurate annotation of genomic variants in human diseases is essential to allow personalized medicine. Assessment of somatic and germline TP53 alterations has now reached the clinic and is required in several circumstances such as the identification of the most effective cancer therapy for patients with chronic lymphocytic leukemia (CLL). Here, we present Seshat, a Web service for annotating TP53 information derived from sequencing data. A flexible framework allows the use of standard file formats such as Mutation Annotation Format (MAF) or Variant Call Format (VCF), as well as common TXT files. Seshat performs accurate variant annotations using the Human Genome Variation Society (HGVS) nomenclature and the stable TP53 genomic reference provided by the Locus Reference Genomic (LRG). In addition, using the 2017 release of the UMD_TP53 database, Seshat provides multiple statistical information for each TP53 variant including database frequency, functional activity, or pathogenicity. The information is delivered in standardized output tables that minimize errors and facilitate comparison of mutational data across studies. Seshat is a beneficial tool to interpret the ever-growing TP53 sequencing data generated by multiple sequencing platforms and it is freely available via the TP53 Website, http://p53.fr or directly at http://vps338341.ovh.net/.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028461
003      
CZ-PrNML
005      
20190822124249.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/humu.23543 $2 doi
035    __
$a (PubMed)29696732
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Tikkanen, Tuomas $u Genevia Technologies, Tampere, Finland.
245    10
$a Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing / $c T. Tikkanen, B. Leroy, JL. Fournier, RA. Risques, J. Malcikova, T. Soussi,
520    9_
$a Accurate annotation of genomic variants in human diseases is essential to allow personalized medicine. Assessment of somatic and germline TP53 alterations has now reached the clinic and is required in several circumstances such as the identification of the most effective cancer therapy for patients with chronic lymphocytic leukemia (CLL). Here, we present Seshat, a Web service for annotating TP53 information derived from sequencing data. A flexible framework allows the use of standard file formats such as Mutation Annotation Format (MAF) or Variant Call Format (VCF), as well as common TXT files. Seshat performs accurate variant annotations using the Human Genome Variation Society (HGVS) nomenclature and the stable TP53 genomic reference provided by the Locus Reference Genomic (LRG). In addition, using the 2017 release of the UMD_TP53 database, Seshat provides multiple statistical information for each TP53 variant including database frequency, functional activity, or pathogenicity. The information is delivered in standardized output tables that minimize errors and facilitate comparison of mutational data across studies. Seshat is a beneficial tool to interpret the ever-growing TP53 sequencing data generated by multiple sequencing platforms and it is freely available via the TP53 Website, http://p53.fr or directly at http://vps338341.ovh.net/.
650    _2
$a výpočetní biologie $x trendy $7 D019295
650    12
$a databáze genetické $7 D030541
650    _2
$a genetická variace $x genetika $7 D014644
650    _2
$a genomika $x trendy $7 D023281
650    _2
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a internet $7 D020407
650    _2
$a anotace sekvence $7 D058977
650    _2
$a mutace $7 D009154
650    12
$a software $7 D012984
650    _2
$a nádorový supresorový protein p53 $x genetika $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Leroy, Bernard $u Sorbonne Université, UPMC Univ Paris, Paris, France.
700    1_
$a Fournier, Jean Louis $u Sorbonne Université, UPMC Univ Paris, Paris, France.
700    1_
$a Risques, Rosa Ana $u Department of Pathology, University of Washington, Seattle, Washington.
700    1_
$a Malcikova, Jitka $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic. Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Soussi, Thierry $u Sorbonne Université, UPMC Univ Paris, Paris, France. Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm, Sweden. INSERM, Centre de Recherche des Cordeliers, U1138, Paris, France.
773    0_
$w MED00002078 $t Human mutation $x 1098-1004 $g Roč. 39, č. 7 (2018), s. 925-933
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29696732 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822124528 $b ABA008
999    __
$a ok $b bmc $g 1433610 $s 1066921
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 39 $c 7 $d 925-933 $e 20180517 $i 1098-1004 $m Human mutation $n Hum Mutat $x MED00002078
GRA    __
$a R01 CA181308 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace